Resorcinol not identified as a substance of very high concern

 At its June meeting, the Member State Committee did not unanimously support France’s proposal to identify resorcinol (EC 203-585-2; CAS 108-46-3) as an SVHC. However, the committee acknowledged that there is scientific evidence that resorcinol is an endocrine disruptor as defined by the World Health Organization (WHO).

Where the MSC is unable to reach a consensus, the European Commission’s REACH Committee will take the final decision. After receiving the MSC’s opinion, the Commission has three months to prepare a draft proposal on the identification as an SVHC and will then make a final decision in its committee procedure.

CONTINUE READING ON echa.europa.eu